Edition:
India

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

56.85USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$56.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,320
52-wk High
$66.38
52-wk Low
$13.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.33 -0.710
Sep '17 7.81 -0.023
Jun '17 0.00 -0.697
FY 2016 Dec '16 17.53 1.122
Sep '16 0.00 -3.731
Jun '16 0.00 -1.702
Mar '16 0.00 -1.811
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.00 0.00 0.00 --
Quarter Ending Sep-18 5 0.00 0.00 0.00 --
Year Ending Dec-18 5 0.00 0.00 0.00 --
Year Ending Dec-19 5 6.02 13.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 4 -0.80 -0.62 -0.96 --
Quarter Ending Sep-18 4 -0.87 -0.63 -1.05 --
Year Ending Dec-18 5 -3.20 -2.53 -3.96 --
Year Ending Dec-19 5 -3.48 -1.79 -6.55 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 67.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Urogen Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.36%
# of Holders: 46
Total Shares Held: 8,575,386
3 Mo. Net Change: 5,482
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.